Exact Sciences (id:5240 EXAS)
52.91 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 2:06:44 AM)
Exchange closed, opens in 1 day 7 hours
About Exact Sciences
Market Capitalization 9.17B
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
| Headquarters (address) |
5505 Endeavor Lane Madison 53719 WI United States |
| Phone | 608 284 5700 |
| Website | https://www.exactsciences.com |
| Employees | 6,500 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Ticker | EXAS |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 40.62 - 79.62 |
| Market Capitalization | 9.17B |
| P/E trailing | -46.82 |
| P/E forward | -145.71 |
| Price/Sale | 3.41 |
| Price/Book | 2.86 |
| Beta | 1.27 |
| EPS | -1.16 |
| EPS United States (ID:6, base:3403) | 24.22 |